Morgan Stanley Ocuphire Pharma, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Morgan Stanley holds 56,096 shares of OCUP stock, worth $54,974. This represents 0.0% of its overall portfolio holdings.

Number of Shares

56,096

Previous 56,105 0.02%

Holding current value

$54,974

Previous $85,000 14.12%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.19 - $2.07 $10 - $18	-9 Reduced 0.02%	56,096 $73,000
Q2 2024 Oct 17, 2024	SELL	$1.51 - $2.23 $13 - $20	-9 Reduced 0.02%	56,105 $85,000
Q2 2024 Aug 14, 2024	SELL	$1.51 - $2.23 $13 - $20	-9 Reduced 0.02%	56,105 $85,000
Q1 2024 Oct 17, 2024	BUY	$1.89 - $3.27 $17 - $29	9 Added 0.02%	56,114 $112,000
Q4 2023 Aug 16, 2024	BUY	$2.59 - $3.64 $23 - $32	9 Added 0.02%	56,114 $168,000
Q4 2023 Feb 13, 2024	BUY	$2.59 - $3.64 $69,375 - $97,501	26,786 Added 91.33%	56,114 $168,000
Q3 2023 Nov 15, 2023	SELL	$3.35 - $4.33 $5,092 - $6,581	-1,520 Reduced 4.93%	29,328 $98,000
Q2 2023 Aug 14, 2023	BUY	$3.63 - $6.38 $8,109 - $14,252	2,234 Added 7.81%	30,848 $133,000
Q1 2023 May 15, 2023	SELL	$3.01 - $3.85 $13,626 - $17,428	-4,527 Reduced 13.66%	28,614 $107,000
Q4 2022 Feb 14, 2023	BUY	$2.04 - $3.53 $1,097 - $1,899	538 Added 1.65%	33,141 $116,000
Q3 2022 Nov 14, 2022	SELL	$1.82 - $2.79 $3,754 - $5,755	-2,063 Reduced 5.95%	32,603 $66,000
Q2 2022 Oct 27, 2022	BUY	$1.8 - $3.25 $20,413 - $36,858	11,341 Added 48.62%	34,666 $67,000
Q2 2022 Aug 15, 2022	BUY	$1.8 - $3.25 $20,413 - $36,858	11,341 Added 48.62%	34,666 $67,000
Q1 2022 Oct 27, 2022	SELL	$2.75 - $4.39 $31,187 - $49,786	-11,341 Reduced 32.72%	23,325 $76,000
Q1 2022 May 13, 2022	BUY	$2.75 - $4.39 $5,500 - $8,780	2,000 Added 9.38%	23,325 $76,000
Q4 2021 Feb 14, 2022	BUY	$3.4 - $5.19 $7,361 - $11,236	2,165 Added 11.3%	21,325 $80,000
Q3 2021 Nov 15, 2021	BUY	$3.84 - $5.38 $73,574 - $103,080	19,160 New	19,160 $99,000

Others Institutions Holding OCUP

# of Institutions

Shares Held

2.58M

Call Options Held

14.1K

Put Options Held

800

View Full List

About Ocuphire Pharma, Inc.

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

More about OCUP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account